dantrolene has been researched along with Cardiovascular Diseases in 2 studies
Dantrolene: Skeletal muscle relaxant that acts by interfering with excitation-contraction coupling in the muscle fiber. It is used in spasticity and other neuromuscular abnormalities. Although the mechanism of action is probably not central, dantrolene is usually grouped with the central muscle relaxants.
dantrolene : The hydrazone resulting from the formal condensation of 5-(4-nitrophenyl)furfural with 1-aminohydantoin. A ryanodine receptor antagonist used for the relief of chronic severe spasticity and malignant hyperthermia.
Cardiovascular Diseases: Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Walker, E | 1 |
| Bezer, G | 1 |
2 other studies available for dantrolene and Cardiovascular Diseases
| Article | Year |
|---|---|
New drugs and new treatments.
Topics: Administration, Topical; Anti-Infective Agents; Anti-Inflammatory Agents; Antineoplastic Agents; Car | 1975 |
Dantrolene sodium intravenous--verapamil.
Topics: Animals; Cardiovascular Diseases; Dantrolene; Drug Interactions; Swine; Verapamil | 1985 |